23andMe Holding Co (ME)
0.50
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
0.5199
+0.02
(+3.98%)
Pre-Market: 08:40
23andMe Cash from Investing (TTM): -10.77M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.77M |
| September 30, 2023 | -11.82M |
| June 30, 2023 | -11.10M |
| March 31, 2023 | -11.30M |
| December 31, 2022 | -11.21M |
| September 30, 2022 | -103.97M |
| Date | Value |
|---|---|
| June 30, 2022 | -109.65M |
| March 31, 2022 | -108.14M |
| December 31, 2021 | -105.73M |
| September 30, 2021 | -10.65M |
| June 30, 2021 | -3.975M |
| March 31, 2021 | -6.536M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-109.65M
Minimum
Jun 2022
-3.975M
Maximum
Jun 2021
-42.07M
Average
-11.26M
Median
Cash from Investing (TTM) Benchmarks
| RadNet Inc | -201.47M |
| DermTech Inc | 29.86M |
| iSpecimen Inc | -7.228M |
| Sera Prognostics Inc | 0.438M |
| Invitae Corp | 316.95M |